sulfamethoxazole has been researched along with Epistaxis in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Epistaxis: Bleeding from the nose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufman, JM | 1 |
| Fauver, HE | 1 |
1 other study available for sulfamethoxazole and Epistaxis
| Article | Year |
|---|---|
Potentiation of warfarin by trimethoprim-sulfamethoxazole.
Topics: Aged; Drug Synergism; Epistaxis; Female; Hematuria; Humans; Male; Middle Aged; Sulfamethoxazole; Tri | 1980 |